Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2016
Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?Tomas Uher, Eva Havrdova, Lukas Sobisek, et al.
Neuroimage. Clinical|November 8, 2014
MRI correlates of disability progression in patients with CIS over 48 monthsTomas Uher, Dana Horakova, Niels Bergsland, et al.
Neuroimage. Clinical|November 22, 2017
Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry studyNiels Bergsland, Dana Horakova, Michael G Dwyer, et al.
BMC Pediatrics|January 31, 2020
Multisystem mitochondrial diseases due to mutations in mtDNA-encoded subunits of complex ITereza Danhelovska, Hana Kolarova, Jiri Zeman, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 3, 2017
A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative StudyTomas Uher, Jan Krasensky, Manuela Vaneckova, et al.
Clinical Toxicology (Philadelphia, Pa.)|April 3, 2018
Role of activation of lipid peroxidation in the mechanisms of acute methanol poisoning<sup>.</sup>Jiri Hlusicka, Tomas Loster, Lucie Lischkova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 8, 2016
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosisTomas Uher, Manuela Vaneckova, Lukas Sobisek, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|February 28, 2018
The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple SclerosisTomas Uher, Jan Krasensky, Lukas Sobisek, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 17, 2021
Evolution of Brain Volume Loss Rates in Early Stages of Multiple SclerosisTomas Uher, Jan Krasensky, Charles Malpas, et al.
Pageof 12